170 related articles for article (PubMed ID: 10148312)
1. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
3. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte-depleted platelets prepared from pooled buffy coat post-transfusion increment and "in vitro bleeding time" using the Thrombostat 4000/2.
Högman CF; Eriksson L; Kristensen J
Transfus Sci; 1993 Jan; 14(1):35-9. PubMed ID: 10148311
[TBL] [Abstract][Full Text] [Related]
5. [Procedure for production of leukocyte depleted erythrocyte and thrombocyte concentrates (PRP method) using top and bottom bags, Optipress automated separators and a computer controlled Cryofuge 6000].
Aulmann M; Ullrich R; Iber B; Neppert J
Beitr Infusionsther; 1992; 30():122-6. PubMed ID: 1284686
[TBL] [Abstract][Full Text] [Related]
6. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
[TBL] [Abstract][Full Text] [Related]
7. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
8. Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system.
Kretschmer V; Biermann E; Loh H
Beitr Infusionsther; 1990; 26():65-70. PubMed ID: 1703903
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
10. Preparation and transfusion of canine platelet concentrates.
Abrams-Ogg AC; Kruth SA; Carter RF; Valli VE; Kamel-Reid S; Dubé ID
Am J Vet Res; 1993 Apr; 54(4):635-42. PubMed ID: 8484587
[TBL] [Abstract][Full Text] [Related]
11. Use of random versus apheresis platelet concentrates.
Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
[TBL] [Abstract][Full Text] [Related]
12. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
Larsson S; Sandgren P; Sjödin A; Vesterinen M; Gulliksson H
Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
[TBL] [Abstract][Full Text] [Related]
13. Platelet concentrates produced from whole blood using the Atreus processing system.
Thomas S; Beard M; Garwood M; Callaert M; Cardigan R
Vox Sang; 2009 Aug; 97(2):93-101. PubMed ID: 19392785
[TBL] [Abstract][Full Text] [Related]
14. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
16. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates.
Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F
Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468
[TBL] [Abstract][Full Text] [Related]
18. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
19. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Porretti L; Murphy S
Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.
van Rhenen DJ; Gulliksson H; Cazenave JP; Pamphilon D; Davis K; Flament J; Corash L
Transfus Med; 2004 Aug; 14(4):289-95. PubMed ID: 15285725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
